Table 3

Risk of death or reoperation within 30 days of surgery for oesophageal cancer, stratified for surgeon volume

Death/reoperation (n=258)Death (n=93)Reoperation (n=191)Anastomotic (n=34)Laparotomy (n=54)Wound within 30 days (n=38)
Weekday of surgerySurgeon volumeOR (95% CI)*OR (95% CI)*OR (95% CI)*OR (95% CI)*OR (95% CI)*OR (95% CI)*
Monday to Tuesday<171 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
Wednesday to Friday<171.02 (0.72 to 1.46)1.31 (0.78 to 2.20)0.88 (0.58 to 1.34)0.64 (0.19 to 2.16)0.73 (0.36 to 1.48)1.55 (0.69 to 3.50)
Monday to Tuesday≥171 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
Wednesday to Friday≥170.94 (0.60 to 1.47)1.22 (0.54 to 2.75)0.87 (0.54 to 1.42)1.26 (0.52 to 3.05)0.79 (0.28 to 2.24)1.25 (0.40 to 3.87)
Monday<171 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
Tuesday<170.87 (0.54 to 1.39)0.55 (0.25 to 1.17)0.90 (0.52 to 1.54)0.94 (0.23 to 3.84)1.55 (0.65 to 3.67)0.53 (0.15 to 1.84)
Wednesday<171.27 (0.78 to 2.05)1.24 (0.63 to 2.45)1.11 (0.63 to 1.93)0.98 (0.22 to 4.47)1.29 (0.50 to 3.33)1.26 (0.43 to 3.71)
Thursday<170.74 (0.41 to 1.32)0.72 (0.31 to 1.63)0.72 (0.37 to 1.43)0.43 (0.05 to 3.90)0.82 (0.24 to 2.75)1.16 (0.35 to 3.79)
Friday<170.58 (0.25 to 1.33)0.92 (0.34 to 2.49)0.32 (0.09 to 1.09)NANA0.96 (0.19 to 4.86)
Monday≥171 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
Tuesday≥171.12 (0.67 to 1.87)0.73 (0.27 to 2.00)1.11 (0.64 to 1.92)0.50 (0.17 to 1.47)0.36 (0.11 to 1.20)2.34 (0.47 to 11.80)
Wednesday≥171.00 (0.50 to 2.02)0.78 (0.20 to 3.05)0.89 (0.41 to 1.94)1.89 (0.66 to 5.39)NA1.09 (0.10 to 12.17)
Thursday≥171.06 (0.54 to 2.05)1.10 (0.35 to 3.49)0.92 (0.44 to 1.92)NA1.14 (0.37 to 3.53)2.95 (0.48 to 18.16)
Friday≥170.85 (0.28 to 2.59)1.48 (0.29 to 7.43)1.03 (0.33 to 3.16)0.85 (0.10 to 7.18)NA2.89 (0.25 to 33.07)
  • Results presented as OR with 95% CI.

  • *Adjusted for age, sex, Charlson comorbidity index, tumour stage, tumour histology, neoadjuvant therapy and surgeon volume.

  • NA, not available.